ABUSNasdaq GS

Arbutus Biopharma Corporation

5.200.00%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tierC
Alert levelExtreme

Tier and alert level are a summary. Unlock ABUS to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

+7.44%, upReturn · 1w
+17.91%, upReturn · 1m
+12.07%, upReturn · 3m
+48.57%, upReturn · 1y
−4.59%, near its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

Price is trading above its key moving averages and momentum readings are contained: the mid-term picture reads as an orderly uptrend. RSI is currently 66.

RSI (14)66.48, favorable readingUpper-neutral
MACD / signal0.15 / 0.08, favorable readingAbove signal line
SMA 504.64, favorable readingPrice above
SMA 2004.47, favorable readingPrice above
EMA 204.79, favorable readingPrice above
ADX (14)22.59Firming
+DI / −DI35.32 / 12.96, favorable reading+DI leading
ATR (14)0.214.1% of price — typical daily swing
Stochastic %K75.73Mid-range
Bollinger bands (20)4.12 – 5.24Inside bands
ROC (10)11.35, favorable readingPositive over 10 sessions
Trend / momentum impulseBoth rising, favorable impulse readingTrend and momentum agree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking ABUS reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock ABUS: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Earnings

When does Arbutus Biopharma Corporation report earnings?

Arbutus Biopharma Corporation (ABUS) is scheduled to report earnings on Nov 16, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Aug 26, 2026

See who else reports soon
Need the raw data?Get ABUS + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock ABUS